Thomas Woiwode, Director, 10% Owner at Tempest Therapeutics, Inc. (TPST), bought 4,237,288 shares at $2.36 ($10.0M) on 2022-04-29, disclosed to the SEC on 2022-05-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.36 | 2,118,644 | $5.0M | 50.0% |
| 2 | $2.36 | 2,118,644 | $5.0M | 50.0% |
| Total | $2.36 avg | 4,237,288 | $10.0M | 100% |
| Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |
| CRSP | SELL | 2018-05-09 | $6.1M | — | Filing → |